Home ➤ Life Science ➤ Pharmaceuticals ➤ Drug Screening Market
Drug Screening Market
Published date: Feb 2025 • Formats:
Request Sample Schedule a Call

Global Drug Screening Market By Product Type (Equipment (Immunoassay Analyzers, Chromatography Instruments, and Breath Analyzers), Consumables (Calibrators & Controls, Assay Kits, and Sample Collection Cups), and Laboratory Services), By Sample Type (Breath, Fluid/Saliva, Hair, and Others), By Drug (Cannabis/Marijuana, Alcohol, Cocaine, and Others), By End-user (Criminal Justice & Law Enforcement Agencies, Workplace & Schools, Drug Testing Laboratories, Hospitals, and Others), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034

  • Published date: Feb 2025
  • Report ID: 141277
  • Number of Pages: 300
  • Format:
  • keyboard_arrow_up

  • Table of Contents

    • 1. Executive Summary
      • 1.1. Definition
      • 1.2. Market Snapshot
      • 1.3. Market Overview
      • 1.4. Segment Overview
      • 1.5. Regional Overview
      • 1.6. Competitive Landscape
      • 1.7. Taxonomy
    • 2. Global Market Overview
      • 2.1. Global Market Insights and Industry Overview
      • 2.2. Market Dynamics
        • 2.2.1. Drivers
        • 2.2.2. Restraints
        • 2.2.3. Opportunities
        • 2.2.4. Key Drug Screening Market Trends
      • 2.3. Regulatory Framework
      • 2.4. Opportunity Map Analysis
      • 2.5. Opportunity Orbits
      • 2.6. PESTLE Analysis
      • 2.7. PORTER’S Five Force Analysis
      • 2.8. Drivers & Restraints Impact Analysis
      • 2.9. Value Chain Analysis
        • 2.9.1. List of Raw Materials Suppliers
        • 2.9.2. List of Drug Screening Manufacturers
        • 2.9.3. List of Dealer/Distributors
      • 2.10. Regional Market Share and BPS Analysis
      • 2.11. Impact of Macro-economic Factors/Geopolitical Factors
    • 3. Global Drug Screening Market Analysis and Forecast, By Segment, 2020-2034
      • 3.1. Key Findings
      • 3.2. Global Drug Screening Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
      • 3.3. Global Drug Screening Market Attractiveness Analysis, By Product Type
        • 3.3.1. Consumables
          • 3.3.1.1. Insights
          • 3.3.1.2. Key Takeaways
            • 3.3.1.2.1. Calibrators & Controls
            • 3.3.1.2.2. Assay Kits
            • 3.3.1.2.3. Sample Collection Cups
        • 3.3.2. Equipment
          • 3.3.2.1. Insights
          • 3.3.2.2. Key Takeaways
            • 3.3.2.2.1. Immunoassay Analyzers
            • 3.3.2.2.2. Chromatography Instruments
            • 3.3.2.2.3. Breath Analyzers
        • 3.3.3. Laboratory Services
          • 3.3.3.1. Insights
          • 3.3.3.2. Key Takeaways
      • 3.4. Global Drug Screening Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Sample Type, 2020-2034
      • 3.5. Global Drug Screening Market Attractiveness Analysis, By Sample Type
        • 3.5.1. Fluid/Saliva
          • 3.5.1.1. Insights
          • 3.5.1.2. Key Takeaways
        • 3.5.2. Breath
          • 3.5.2.1. Insights
          • 3.5.2.2. Key Takeaways
        • 3.5.3. Hair
          • 3.5.3.1. Insights
          • 3.5.3.2. Key Takeaways
        • 3.5.4. Others
          • 3.5.4.1. Insights
          • 3.5.4.2. Key Takeaways
      • 3.6. Global Drug Screening Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug, 2020-2034
      • 3.7. Global Drug Screening Market Attractiveness Analysis, By Drug
        • 3.7.1. Cannabis/Marijuana
          • 3.7.1.1. Insights
          • 3.7.1.2. Key Takeaways
        • 3.7.2. Alcohol
          • 3.7.2.1. Insights
          • 3.7.2.2. Key Takeaways
        • 3.7.3. Cocaine
          • 3.7.3.1. Insights
          • 3.7.3.2. Key Takeaways
        • 3.7.4. Others
          • 3.7.4.1. Insights
          • 3.7.4.2. Key Takeaways
      • 3.8. Global Drug Screening Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2020-2034
      • 3.9. Global Drug Screening Market Attractiveness Analysis, By End-user
        • 3.9.1. Drug Testing Laboratories
          • 3.9.1.1. Insights
          • 3.9.1.2. Key Takeaways
        • 3.9.2. Criminal Justice & Law Enforcement Agencies
          • 3.9.2.1. Insights
          • 3.9.2.2. Key Takeaways
        • 3.9.3. Workplace & Schools
          • 3.9.3.1. Insights
          • 3.9.3.2. Key Takeaways
        • 3.9.4. Hospitals
          • 3.9.4.1. Insights
          • 3.9.4.2. Key Takeaways
        • 3.9.5. Others
          • 3.9.5.1. Insights
          • 3.9.5.2. Key Takeaways
    • 4. Global Drug Screening Market Analysis and Forecast, By Region, 2020-2034
      • 4.1. Key Findings
      • 4.2. Global Drug Screening Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Region, 2020-2034
        • 4.2.1. North America
          • 4.2.1.1. Regional Insights
        • 4.2.2. Europe
          • 4.2.2.1. Regional Insights
        • 4.2.3. Asia Pacific
          • 4.2.3.1. Regional Insights
        • 4.2.4. Latin America
          • 4.2.4.1. Regional Insights
        • 4.2.5. Middle East & Africa
          • 4.2.5.1. Regional Insights
      • 4.3. Global Drug Screening Market Attractiveness Analysis, By Region
    • 5. North America Drug Screening Market Analysis and Forecast, 2020-2034
      • 5.1. Key Findings
      • 5.2. North America Drug Screening Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
      • 5.3. North America Drug Screening Market Attractiveness Analysis, By Product Type
      • 5.4. North America Drug Screening Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Sample Type, 2020-2034
      • 5.5. North America Drug Screening Market Attractiveness Analysis, By Sample Type
      • 5.6. North America Drug Screening Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug, 2020-2034
      • 5.7. North America Drug Screening Market Attractiveness Analysis, By Drug
      • 5.8. North America Drug Screening Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2020-2034
      • 5.9. North America Drug Screening Market Attractiveness Analysis, By End-user
      • 5.10. North America Drug Screening Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
      • 5.11. North America Drug Screening Market Attractiveness Analysis, By Country
        • 5.11.1. The US
        • 5.11.2. Canada
    • 6. Europe Drug Screening Market Analysis and Forecast, 2020-2034
      • 6.1. Key Findings
      • 6.2. Europe Drug Screening Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
      • 6.3. Europe Drug Screening Market Attractiveness Analysis, By Product Type
      • 6.4. Europe Drug Screening Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Sample Type, 2020-2034
      • 6.5. Europe Drug Screening Market Attractiveness Analysis, By Sample Type
      • 6.6. Europe Drug Screening Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug, 2020-2034
      • 6.7. Europe Drug Screening Market Attractiveness Analysis, By Drug
      • 6.8. Europe Drug Screening Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2020-2034
      • 6.9. Europe Drug Screening Market Attractiveness Analysis, By End-user
      • 6.10. Europe Drug Screening Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
      • 6.11. Europe Drug Screening Market Attractiveness Analysis, By Country
        • 6.11.1. Germany
        • 6.11.2. The UK
        • 6.11.3. France
        • 6.11.4. Spain
        • 6.11.5. Italy
        • 6.11.6. Russia
        • 6.11.7. Netherland
        • 6.11.8. Rest of Europe
    • 7. Asia Pacific Drug Screening Market Analysis and Forecast, 2020-2034
      • 7.1. Key Findings
      • 7.2. Asia Pacific Drug Screening Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
      • 7.3. Asia Pacific Drug Screening Market Attractiveness Analysis, By Product Type
      • 7.4. Asia Pacific Drug Screening Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Sample Type, 2020-2034
      • 7.5. Asia Pacific Drug Screening Market Attractiveness Analysis, By Sample Type
      • 7.6. Asia Pacific Drug Screening Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug, 2020-2034
      • 7.7. Asia Pacific Drug Screening Market Attractiveness Analysis, By Drug
      • 7.8. Asia Pacific Drug Screening Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2020-2034
      • 7.9. Asia Pacific Drug Screening Market Attractiveness Analysis, By End-user
      • 7.10. Asia Pacific Drug Screening Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
      • 7.11. Asia Pacific Drug Screening Market Attractiveness Analysis, By Country
        • 7.11.1. China
        • 7.11.2. Japan
        • 7.11.3. South Korea
        • 7.11.4. India
        • 7.11.5. Australia
        • 7.11.6. New Zealand
        • 7.11.7. Singapore
        • 7.11.8. Thailand
        • 7.11.9. Vietnam
        • 7.11.10. Rest of Asia Pacific
    • 8. Latin America Drug Screening Market Analysis and Forecast, 2020-2034
      • 8.1. Key Findings
      • 8.2. Latin America Drug Screening Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
      • 8.3. Latin America Drug Screening Market Attractiveness Analysis, By Product Type
      • 8.4. Latin America Drug Screening Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Sample Type, 2020-2034
      • 8.5. Latin America Drug Screening Market Attractiveness Analysis, By Sample Type
      • 8.6. Latin America Drug Screening Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug, 2020-2034
      • 8.7. Latin America Drug Screening Market Attractiveness Analysis, By Drug
      • 8.8. Latin America Drug Screening Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2020-2034
      • 8.9. Latin America Drug Screening Market Attractiveness Analysis, By End-user
      • 8.10. Latin America Drug Screening Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
      • 8.11. Latin America Drug Screening Market Attractiveness Analysis, By Country
        • 8.11.1. Brazil
        • 8.11.2. Mexico
        • 8.11.3. Rest of Latin America
    • 9. Middle East & Africa Drug Screening Market Analysis and Forecast, 2020-2034
      • 9.1. Key Findings
      • 9.2. Middle East & Africa Drug Screening Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
      • 9.3. Middle East & Africa Drug Screening Market Attractiveness Analysis, By Product Type
      • 9.4. Middle East & Africa Drug Screening Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Sample Type, 2020-2034
      • 9.5. Middle East & Africa Drug Screening Market Attractiveness Analysis, By Sample Type
      • 9.6. Middle East & Africa Drug Screening Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug, 2020-2034
      • 9.7. Middle East & Africa Drug Screening Market Attractiveness Analysis, By Drug
      • 9.8. Middle East & Africa Drug Screening Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2020-2034
      • 9.9. Middle East & Africa Drug Screening Market Attractiveness Analysis, By End-user
      • 9.10. Middle East & Africa Drug Screening Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
      • 9.11. Middle East & Africa Drug Screening Market Attractiveness Analysis, By Country
        • 9.11.1. South Africa
        • 9.11.2. Saudi Arabia
        • 9.11.3. UAE
        • 9.11.4. Rest of Middle East & Africa
    • 10. Competitive Landscape & Company Profiles
      • 10.1. Market Competition Scenario Analysis, By Company
      • 10.1.1. Key Takeaways
      • 10.2. Overview of Major Market Players
      • 10.3. Competitor Landscape
      • 10.4. Strategic Mapping
      • 10.5. Company Life Cycle Analysis
      • 10.6. Company Market Share Analysis
      • 10.7. Company Profiles
        • 10.7.1. Synergy Health plc
          • 10.7.1.1. Company Details
          • 10.7.1.2. Business Overview
          • 10.7.1.3. Product Portfolio
          • 10.7.1.4. Financial Insights
          • 10.7.1.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.1.6. SWOT Analysis
          • 10.7.1.7. Geographic Footprint
        • 10.7.2. Quest Diagnostics
          • 10.7.2.1. Company Details
          • 10.7.2.2. Business Overview
          • 10.7.2.3. Product Portfolio
          • 10.7.2.4. Financial Insights
          • 10.7.2.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.2.6. SWOT Analysis
          • 10.7.2.7. Geographic Footprint
        • 10.7.3. ICE Bioscience
          • 10.7.3.1. Company Details
          • 10.7.3.2. Business Overview
          • 10.7.3.3. Product Portfolio
          • 10.7.3.4. Financial Insights
          • 10.7.3.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.3.6. SWOT Analysis
          • 10.7.3.7. Geographic Footprint
        • 10.7.4. Danaher
          • 10.7.4.1. Company Details
          • 10.7.4.2. Business Overview
          • 10.7.4.3. Product Portfolio
          • 10.7.4.4. Financial Insights
          • 10.7.4.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.4.6. SWOT Analysis
          • 10.7.4.7. Geographic Footprint
        • 10.7.5. Broughton
          • 10.7.5.1. Company Details
          • 10.7.5.2. Business Overview
          • 10.7.5.3. Product Portfolio
          • 10.7.5.4. Financial Insights
          • 10.7.5.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.5.6. SWOT Analysis
          • 10.7.5.7. Geographic Footprint
        • 10.7.6. BioMerieux SA
          • 10.7.6.1. Company Details
          • 10.7.6.2. Business Overview
          • 10.7.6.3. Product Portfolio
          • 10.7.6.4. Financial Insights
          • 10.7.6.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.6.6. SWOT Analysis
          • 10.7.6.7. Geographic Footprint
        • 10.7.7. Biomedical Diagnostics
          • 10.7.7.1. Company Details
          • 10.7.7.2. Business Overview
          • 10.7.7.3. Product Portfolio
          • 10.7.7.4. Financial Insights
          • 10.7.7.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.7.6. SWOT Analysis
          • 10.7.7.7. Geographic Footprint
        • 10.7.8. Abbott
          • 10.7.8.1. Company Details
          • 10.7.8.2. Business Overview
          • 10.7.8.3. Product Portfolio
          • 10.7.8.4. Financial Insights
          • 10.7.8.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.8.6. SWOT Analysis
          • 10.7.8.7. Geographic Footprint
    • 11. Methodology and Data Source
      • 11.1. Methodology/Research Approach
      • 11.2. Market Size Estimation
      • 11.3. Market Breakdown and Data Triangulation
      • 11.4. Data Source
      • 11.5. Secondary Sources
      • 11.6. Primary Sources
      • 11.7. Appendix
      • 11.8. Disclaimer

    List of Tables

    • Table 1. Global Drug Screening Market Value (US$ Mn), By Product Type, 2020-2034
    • Table 2. Global Drug Screening Market Value (US$ Mn), By Sample Type, 2020-2034
    • Table 3. Global Drug Screening Market Value (US$ Mn), By Drug, 2020-2034
    • Table 4. Global Drug Screening Market Value (US$ Mn), By End-user, 2020-2034
    • Table 5. Global Drug Screening Market Value (US$ Mn), By Region, 2020-2034
    • Table 6. North America Drug Screening Market Value (US$ Mn), By Product Type, 2020-2034
    • Table 7. North America Drug Screening Market Value (US$ Mn), By Sample Type, 2020-2034
    • Table 8. North America Drug Screening Market Value (US$ Mn), By Drug, 2020-2034
    • Table 9. North America Drug Screening Market Value (US$ Mn), By End-user, 2020-2034
    • Table 10. North America Drug Screening Market Value (US$ Mn), By Country, 2020-2034
    • Table 11. The US Drug Screening Market Value (US$ Mn), By Product Type, 2020-2034
    • Table 12. The US Drug Screening Market Value (US$ Mn), By Sample Type, 2020-2034
    • Table 13. The US Drug Screening Market Value (US$ Mn), By Drug, 2020-2034
    • Table 14. The US Drug Screening Market Value (US$ Mn), By End-user, 2020-2034
    • Table 15. Canada Drug Screening Market Value (US$ Mn), By Product Type, 2020-2034
    • Table 16. Canada Drug Screening Market Value (US$ Mn), By Sample Type, 2020-2034
    • Table 17. Canada Drug Screening Market Value (US$ Mn), By Drug, 2020-2034
    • Table 18. Canada Drug Screening Market Value (US$ Mn), By End-user, 2020-2034
    • Table 19. Europe Drug Screening Market Value (US$ Mn), By Product Type, 2020-2034
    • Table 20. Europe Drug Screening Market Value (US$ Mn), By Sample Type, 2020-2034
    • Table 21. Europe Drug Screening Market Value (US$ Mn), By Drug, 2020-2034
    • Table 22. Europe Drug Screening Market Value (US$ Mn), By End-user, 2020-2034
    • Table 23. Europe Drug Screening Market Value (US$ Mn), By Country, 2020-2034
    • Table 24. Germany Drug Screening Market Value (US$ Mn), By Product Type, 2020-2034
    • Table 25. Germany Drug Screening Market Value (US$ Mn), By Sample Type, 2020-2034
    • Table 26. Germany Drug Screening Market Value (US$ Mn), By Drug, 2020-2034
    • Table 27. Germany Drug Screening Market Value (US$ Mn), By End-user, 2020-2034
    • Table 28. The UK Drug Screening Market Value (US$ Mn), By Product Type, 2020-2034
    • Table 29. The UK Drug Screening Market Value (US$ Mn), By Sample Type, 2020-2034
    • Table 30. The UK Drug Screening Market Value (US$ Mn), By Drug, 2020-2034
    • Table 31. The UK Drug Screening Market Value (US$ Mn), By End-user, 2020-2034
    • Table 32. France Drug Screening Market Value (US$ Mn), By Product Type, 2020-2034
    • Table 33. France Drug Screening Market Value (US$ Mn), By Sample Type, 2020-2034
    • Table 34. France Drug Screening Market Value (US$ Mn), By Drug, 2020-2034
    • Table 35. France Drug Screening Market Value (US$ Mn), By End-user, 2020-2034
    • Table 36. Spain Drug Screening Market Value (US$ Mn), By Product Type, 2020-2034
    • Table 37. Spain Drug Screening Market Value (US$ Mn), By Sample Type, 2020-2034
    • Table 38. Spain Drug Screening Market Value (US$ Mn), By Drug, 2020-2034
    • Table 39. Spain Drug Screening Market Value (US$ Mn), By End-user, 2020-2034
    • Table 40. Italy Drug Screening Market Value (US$ Mn), By Product Type, 2020-2034
    • Table 41. Italy Drug Screening Market Value (US$ Mn), By Sample Type, 2020-2034
    • Table 42. Italy Drug Screening Market Value (US$ Mn), By Drug, 2020-2034
    • Table 43. Italy Drug Screening Market Value (US$ Mn), By End-user, 2020-2034
    • Table 44. Russia Drug Screening Market Value (US$ Mn), By Product Type, 2020-2034
    • Table 45. Russia Drug Screening Market Value (US$ Mn), By Sample Type, 2020-2034
    • Table 46. Russia Drug Screening Market Value (US$ Mn), By Drug, 2020-2034
    • Table 47. Russia Drug Screening Market Value (US$ Mn), By End-user, 2020-2034
    • Table 48. Netherland Drug Screening Market Value (US$ Mn), By Product Type, 2020-2034
    • Table 49. Netherland Drug Screening Market Value (US$ Mn), By Sample Type, 2020-2034
    • Table 50. Netherland Drug Screening Market Value (US$ Mn), By Drug, 2020-2034
    • Table 51. Netherland Drug Screening Market Value (US$ Mn), By End-user, 2020-2034
    • Table 52. Rest of Europe Drug Screening Market Value (US$ Mn), By Product Type, 2020-2034
    • Table 53. Rest of Europe Drug Screening Market Value (US$ Mn), By Sample Type, 2020-2034
    • Table 54. Rest of Europe Drug Screening Market Value (US$ Mn), By Drug, 2020-2034
    • Table 55. Rest of Europe Drug Screening Market Value (US$ Mn), By End-user, 2020-2034
    • Table 56. Asia Pacific Drug Screening Market Value (US$ Mn), By Product Type, 2020-2034
    • Table 57. Asia Pacific Drug Screening Market Value (US$ Mn), By Sample Type, 2020-2034
    • Table 58. Asia Pacific Drug Screening Market Value (US$ Mn), By Drug, 2020-2034
    • Table 59. Asia Pacific Drug Screening Market Value (US$ Mn), By End-user, 2020-2034
    • Table 60. Asia Pacific Drug Screening Market Value (US$ Mn), By Country, 2020-2034
    • Table 61. China Drug Screening Market Value (US$ Mn), By Product Type, 2020-2034
    • Table 62. China Drug Screening Market Value (US$ Mn), By Sample Type, 2020-2034
    • Table 63. China Drug Screening Market Value (US$ Mn), By Drug, 2020-2034
    • Table 64. China Drug Screening Market Value (US$ Mn), By End-user, 2020-2034
    • Table 65. India Drug Screening Market Value (US$ Mn), By Product Type, 2020-2034
    • Table 66. India Drug Screening Market Value (US$ Mn), By Sample Type, 2020-2034
    • Table 67. India Drug Screening Market Value (US$ Mn), By Drug, 2020-2034
    • Table 68. India Drug Screening Market Value (US$ Mn), By End-user, 2020-2034
    • Table 69. Japan Drug Screening Market Value (US$ Mn), By Product Type, 2020-2034
    • Table 70. Japan Drug Screening Market Value (US$ Mn), By Sample Type, 2020-2034
    • Table 71. Japan Drug Screening Market Value (US$ Mn), By Drug, 2020-2034
    • Table 72. Japan Drug Screening Market Value (US$ Mn), By End-user, 2020-2034
    • Table 73. South Korea Drug Screening Market Value (US$ Mn), By Product Type, 2020-2034
    • Table 74. South Korea Drug Screening Market Value (US$ Mn), By Sample Type, 2020-2034
    • Table 75. South Korea Drug Screening Market Value (US$ Mn), By Drug, 2020-2034
    • Table 76. South Korea Drug Screening Market Value (US$ Mn), By End-user, 2020-2034
    • Table 77. Australia Drug Screening Market Value (US$ Mn), By Product Type, 2020-2034
    • Table 78. Australia Drug Screening Market Value (US$ Mn), By Sample Type, 2020-2034
    • Table 79. Australia Drug Screening Market Value (US$ Mn), By Drug, 2020-2034
    • Table 80. Australia Drug Screening Market Value (US$ Mn), By End-user, 2020-2034
    • Table 81. New Zealand Drug Screening Market Value (US$ Mn), By Product Type, 2020-2034
    • Table 82. New Zealand Drug Screening Market Value (US$ Mn), By Sample Type, 2020-2034
    • Table 83. New Zealand Drug Screening Market Value (US$ Mn), By Drug, 2020-2034
    • Table 84. New Zealand Drug Screening Market Value (US$ Mn), By End-user, 2020-2034
    • Table 85. Singapore Drug Screening Market Value (US$ Mn), By Product Type, 2020-2034
    • Table 86. Singapore Drug Screening Market Value (US$ Mn), By Sample Type, 2020-2034
    • Table 87. Singapore Drug Screening Market Value (US$ Mn), By Drug, 2020-2034
    • Table 88. Singapore Drug Screening Market Value (US$ Mn), By End-user, 2020-2034
    • Table 89. Thailand Drug Screening Market Value (US$ Mn), By Product Type, 2020-2034
    • Table 90. Thailand Drug Screening Market Value (US$ Mn), By Sample Type, 2020-2034
    • Table 91. Thailand Drug Screening Market Value (US$ Mn), By Drug, 2020-2034
    • Table 92. Thailand Drug Screening Market Value (US$ Mn), By End-user, 2020-2034
    • Table 93. Vietnam Drug Screening Market Value (US$ Mn), By Product Type, 2020-2034
    • Table 94. Vietnam Drug Screening Market Value (US$ Mn), By Sample Type, 2020-2034
    • Table 95. Vietnam Drug Screening Market Value (US$ Mn), By Drug, 2020-2034
    • Table 96. Vietnam Drug Screening Market Value (US$ Mn), By End-user, 2020-2034
    • Table 97. Rest of Asia Pacific Drug Screening Market Value (US$ Mn), By Product Type, 2020-2034
    • Table 98. Rest of Asia Pacific Drug Screening Market Value (US$ Mn), By Sample Type, 2020-2034
    • Table 99. Rest of Asia Pacific Drug Screening Market Value (US$ Mn), By Drug, 2020-2034
    • Table 100. Rest of Asia Pacific Drug Screening Market Value (US$ Mn), By End-user, 2020-2034
    • Table 101. Latin America Drug Screening Market Value (US$ Mn), By Product Type, 2020-2034
    • Table 102. Latin America Drug Screening Market Value (US$ Mn), By Sample Type, 2020-2034
    • Table 103. Latin America Drug Screening Market Value (US$ Mn), By Drug, 2020-2034
    • Table 104. Latin America Drug Screening Market Value (US$ Mn), By End-user, 2020-2034
    • Table 105. Latin America Drug Screening Market Value (US$ Mn), By Country, 2020-2034
    • Table 106. Brazil Drug Screening Market Value (US$ Mn), By Product Type, 2020-2034
    • Table 107. Brazil Drug Screening Market Value (US$ Mn), By Sample Type, 2020-2034
    • Table 108. Brazil Drug Screening Market Value (US$ Mn), By Drug, 2020-2034
    • Table 109. Brazil Drug Screening Market Value (US$ Mn), By End-user, 2020-2034
    • Table 110. Mexico Drug Screening Market Value (US$ Mn), By Product Type, 2020-2034
    • Table 111. Mexico Drug Screening Market Value (US$ Mn), By Sample Type, 2020-2034
    • Table 112. Mexico Drug Screening Market Value (US$ Mn), By Drug, 2020-2034
    • Table 113. Mexico Drug Screening Market Value (US$ Mn), By End-user, 2020-2034
    • Table 114. Rest of Latin America Drug Screening Market Value (US$ Mn), By Product Type, 2020-2034
    • Table 115. Rest of Latin America Drug Screening Market Value (US$ Mn), By Sample Type, 2020-2034
    • Table 116. Rest of Latin America Drug Screening Market Value (US$ Mn), By Drug, 2020-2034
    • Table 117. Rest of Latin America Drug Screening Market Value (US$ Mn), By End-user, 2020-2034
    • Table 118. Middle East & Africa Drug Screening Market Value (US$ Mn), By Product Type, 2020-2034
    • Table 119. Middle East & Africa Drug Screening Market Value (US$ Mn), By Sample Type, 2020-2034
    • Table 120. Middle East & Africa Drug Screening Market Value (US$ Mn), By Drug, 2020-2034
    • Table 121. Middle East & Africa Drug Screening Market Value (US$ Mn), By End-user, 2020-2034
    • Table 122. Middle East & Africa Drug Screening Market Value (US$ Mn), By Country, 2020-2034
    • Table 123. South Africa Drug Screening Market Value (US$ Mn), By Product Type, 2020-2034
    • Table 124. South Africa Drug Screening Market Value (US$ Mn), By Sample Type, 2020-2034
    • Table 125. South Africa Drug Screening Market Value (US$ Mn), By Drug, 2020-2034
    • Table 126. South Africa Drug Screening Market Value (US$ Mn), By End-user, 2020-2034
    • Table 127. Saudi Arabia Drug Screening Market Value (US$ Mn), By Product Type, 2020-2034
    • Table 128. Saudi Arabia Drug Screening Market Value (US$ Mn), By Sample Type, 2020-2034
    • Table 129. Saudi Arabia Drug Screening Market Value (US$ Mn), By Drug, 2020-2034
    • Table 130. Saudi Arabia Drug Screening Market Value (US$ Mn), By End-user, 2020-2034
    • Table 131. UAE Drug Screening Market Value (US$ Mn), By Product Type, 2020-2034
    • Table 132. UAE Drug Screening Market Value (US$ Mn), By Sample Type, 2020-2034
    • Table 133. UAE Drug Screening Market Value (US$ Mn), By Drug, 2020-2034
    • Table 134. UAE Drug Screening Market Value (US$ Mn), By End-user, 2020-2034
    • Table 135. Rest of Middle East & Africa Drug Screening Market Value (US$ Mn), By Product Type, 2020-2034
    • Table 136. Rest of Middle East & Africa Drug Screening Market Value (US$ Mn), By Sample Type, 2020-2034
    • Table 137. Rest of Middle East & Africa Drug Screening Market Value (US$ Mn), By Drug, 2020-2034
    • Table 138. Rest of Middle East & Africa Drug Screening Market Value (US$ Mn), By End-user, 2020-2034

    List of Figures

    • Figure 1. Global Drug Screening Market Snapshot: Market Value (US$ Mn), 2020-2034
    • Figure 2. Opportunity Map
    • Figure 3. Opportunity Orbit
    • Figure 4. Regional Market Share and BPS Analysis in Drug Screening Market
    • Figure 5. Global Drug Screening Market Analysis, By Product Type, 2020, 2024 and 2034
    • Figure 6. Global Drug Screening Market Attractiveness Analysis, By Product Type
    • Figure 7. Global Drug Screening Market Analysis, By Sample Type, 2020, 2024 and 2034
    • Figure 8. Global Drug Screening Market Attractiveness Analysis, By Sample Type
    • Figure 9. Global Drug Screening Market Analysis, By Drug, 2020, 2024 and 2034
    • Figure 10. Global Drug Screening Market Attractiveness Analysis, By Drug
    • Figure 11. Global Drug Screening Market Analysis, By End-user, 2020, 2024 and 2034
    • Figure 12. Global Drug Screening Market Attractiveness Analysis, By End-user
    • Figure 13. Global Drug Screening Market Analysis, By Region, 2020, 2024 and 2034
    • Figure 14. Global Drug Screening Market Attractiveness Analysis, By Region
    • Figure 15. North America Drug Screening Market Analysis, By Product Type, 2020, 2024 and 2034
    • Figure 16. North America Drug Screening Market Attractiveness Analysis, By Product Type
    • Figure 17. North America Drug Screening Market (US$ Mn), by Consumables, 2020-2034
    • Figure 18. North America Drug Screening Market (US$ Mn), by Equipment, 2020-2034
    • Figure 19. North America Drug Screening Market (US$ Mn), by Laboratory Services, 2020-2034
    • Figure 20. North America Drug Screening Market Analysis, By Sample Type, 2020, 2024 and 2034
    • Figure 21. North America Drug Screening Market Attractiveness Analysis, By Sample Type
    • Figure 22. North America Drug Screening Market (US$ Mn), by Fluid/Saliva, 2020-2034
    • Figure 23. North America Drug Screening Market (US$ Mn), by Breath, 2020-2034
    • Figure 24. North America Drug Screening Market (US$ Mn), by Hair, 2020-2034
    • Figure 25. North America Drug Screening Market (US$ Mn), by Others, 2020-2034
    • Figure 26. North America Drug Screening Market Analysis, By Drug, 2020, 2024 and 2034
    • Figure 27. North America Drug Screening Market Attractiveness Analysis, By Drug
    • Figure 28. North America Drug Screening Market (US$ Mn), by Cannabis/Marijuana, 2020-2034
    • Figure 29. North America Drug Screening Market (US$ Mn), by Alcohol, 2020-2034
    • Figure 30. North America Drug Screening Market (US$ Mn), by Cocaine, 2020-2034
    • Figure 31. North America Drug Screening Market (US$ Mn), by Others, 2020-2034
    • Figure 32. North America Drug Screening Market Analysis, By End-user, 2020, 2024 and 2034
    • Figure 33. North America Drug Screening Market Attractiveness Analysis, By End-user
    • Figure 34. North America Drug Screening Market (US$ Mn), by Drug Testing Laboratories, 2020-2034
    • Figure 35. North America Drug Screening Market (US$ Mn), by Criminal Justice & Law Enforcement Agencies, 2020-2034
    • Figure 36. North America Drug Screening Market (US$ Mn), by Workplace & Schools, 2020-2034
    • Figure 37. North America Drug Screening Market (US$ Mn), by Hospitals, 2020-2034
    • Figure 38. North America Drug Screening Market (US$ Mn), by Others, 2020-2034
    • Figure 39. North America Drug Screening Market Analysis, By Country, 2020, 2024 and 2034
    • Figure 40. North America Drug Screening Market Attractiveness Analysis, By Country
    • Figure 41. Europe Drug Screening Market Analysis, By Product Type, 2020, 2024 and 2034
    • Figure 42. Europe Drug Screening Market Attractiveness Analysis, By Product Type
    • Figure 43. Europe Drug Screening Market (US$ Mn), by Consumables, 2020-2034
    • Figure 44. Europe Drug Screening Market (US$ Mn), by Equipment, 2020-2034
    • Figure 45. Europe Drug Screening Market (US$ Mn), by Laboratory Services, 2020-2034
    • Figure 46. Europe Drug Screening Market Analysis, By Sample Type, 2020, 2024 and 2034
    • Figure 47. Europe Drug Screening Market Attractiveness Analysis, By Sample Type
    • Figure 48. Europe Drug Screening Market (US$ Mn), by Fluid/Saliva, 2020-2034
    • Figure 49. Europe Drug Screening Market (US$ Mn), by Breath, 2020-2034
    • Figure 50. Europe Drug Screening Market (US$ Mn), by Hair, 2020-2034
    • Figure 51. Europe Drug Screening Market (US$ Mn), by Others, 2020-2034
    • Figure 52. Europe Drug Screening Market Analysis, By Drug, 2020, 2024 and 2034
    • Figure 53. Europe Drug Screening Market Attractiveness Analysis, By Drug
    • Figure 54. Europe Drug Screening Market (US$ Mn), by Cannabis/Marijuana, 2020-2034
    • Figure 55. Europe Drug Screening Market (US$ Mn), by Alcohol, 2020-2034
    • Figure 56. Europe Drug Screening Market (US$ Mn), by Cocaine, 2020-2034
    • Figure 57. Europe Drug Screening Market (US$ Mn), by Others, 2020-2034
    • Figure 58. Europe Drug Screening Market Analysis, By End-user, 2020, 2024 and 2034
    • Figure 59. Europe Drug Screening Market Attractiveness Analysis, By End-user
    • Figure 60. Europe Drug Screening Market (US$ Mn), by Drug Testing Laboratories, 2020-2034
    • Figure 61. Europe Drug Screening Market (US$ Mn), by Criminal Justice & Law Enforcement Agencies, 2020-2034
    • Figure 62. Europe Drug Screening Market (US$ Mn), by Workplace & Schools, 2020-2034
    • Figure 63. Europe Drug Screening Market (US$ Mn), by Hospitals, 2020-2034
    • Figure 64. Europe Drug Screening Market (US$ Mn), by Others, 2020-2034
    • Figure 65. Europe Drug Screening Market Analysis, By Country, 2020, 2024 and 2034
    • Figure 66. Europe Drug Screening Market Attractiveness Analysis, By Country
    • Figure 67. Asia Pacific Drug Screening Market Analysis, By Product Type, 2020, 2024 and 2034
    • Figure 68. Asia Pacific Drug Screening Market Attractiveness Analysis, By Product Type
    • Figure 69. Asia Pacific Drug Screening Market (US$ Mn), by Consumables, 2020-2034
    • Figure 70. Asia Pacific Drug Screening Market (US$ Mn), by Equipment, 2020-2034
    • Figure 71. Asia Pacific Drug Screening Market (US$ Mn), by Laboratory Services, 2020-2034
    • Figure 72. Asia Pacific Drug Screening Market Analysis, By Sample Type, 2020, 2024 and 2034
    • Figure 73. Asia Pacific Drug Screening Market Attractiveness Analysis, By Sample Type
    • Figure 74. Asia Pacific Drug Screening Market (US$ Mn), by Fluid/Saliva, 2020-2034
    • Figure 75. Asia Pacific Drug Screening Market (US$ Mn), by Breath, 2020-2034
    • Figure 76. Asia Pacific Drug Screening Market (US$ Mn), by Hair, 2020-2034
    • Figure 77. Asia Pacific Drug Screening Market (US$ Mn), by Others, 2020-2034
    • Figure 78. Asia Pacific Drug Screening Market Analysis, By Drug, 2020, 2024 and 2034
    • Figure 79. Asia Pacific Drug Screening Market Attractiveness Analysis, By Drug
    • Figure 80. Asia Pacific Drug Screening Market (US$ Mn), by Cannabis/Marijuana, 2020-2034
    • Figure 81. Asia Pacific Drug Screening Market (US$ Mn), by Alcohol, 2020-2034
    • Figure 82. Asia Pacific Drug Screening Market (US$ Mn), by Cocaine, 2020-2034
    • Figure 83. Asia Pacific Drug Screening Market (US$ Mn), by Others, 2020-2034
    • Figure 84. Asia Pacific Drug Screening Market Analysis, By End-user, 2020, 2024 and 2034
    • Figure 85. Asia Pacific Drug Screening Market Attractiveness Analysis, By End-user
    • Figure 86. Asia Pacific Drug Screening Market (US$ Mn), by Drug Testing Laboratories, 2020-2034
    • Figure 87. Asia Pacific Drug Screening Market (US$ Mn), by Criminal Justice & Law Enforcement Agencies, 2020-2034
    • Figure 88. Asia Pacific Drug Screening Market (US$ Mn), by Workplace & Schools, 2020-2034
    • Figure 89. Asia Pacific Drug Screening Market (US$ Mn), by Hospitals, 2020-2034
    • Figure 90. Asia Pacific Drug Screening Market (US$ Mn), by Others, 2020-2034
    • Figure 91. Asia Pacific Drug Screening Market Analysis, By Country, 2020, 2024 and 2034
    • Figure 92. Asia Pacific Drug Screening Market Attractiveness Analysis, By Country
    • Figure 93. Latin America Drug Screening Market Analysis, By Product Type, 2020, 2024 and 2034
    • Figure 94. Latin America Drug Screening Market Attractiveness Analysis, By Product Type
    • Figure 95. Latin America Drug Screening Market (US$ Mn), by Consumables, 2020-2034
    • Figure 96. Latin America Drug Screening Market (US$ Mn), by Equipment, 2020-2034
    • Figure 97. Latin America Drug Screening Market (US$ Mn), by Laboratory Services, 2020-2034
    • Figure 98. Latin America Drug Screening Market Analysis, By Sample Type, 2020, 2024 and 2034
    • Figure 99. Latin America Drug Screening Market Attractiveness Analysis, By Sample Type
    • Figure 100. Latin America Drug Screening Market (US$ Mn), by Fluid/Saliva, 2020-2034
    • Figure 101. Latin America Drug Screening Market (US$ Mn), by Breath, 2020-2034
    • Figure 102. Latin America Drug Screening Market (US$ Mn), by Hair, 2020-2034
    • Figure 103. Latin America Drug Screening Market (US$ Mn), by Others, 2020-2034
    • Figure 104. Latin America Drug Screening Market Analysis, By Drug, 2020, 2024 and 2034
    • Figure 105. Latin America Drug Screening Market Attractiveness Analysis, By Drug
    • Figure 106. Latin America Drug Screening Market (US$ Mn), by Cannabis/Marijuana, 2020-2034
    • Figure 107. Latin America Drug Screening Market (US$ Mn), by Alcohol, 2020-2034
    • Figure 108. Latin America Drug Screening Market (US$ Mn), by Cocaine, 2020-2034
    • Figure 109. Latin America Drug Screening Market (US$ Mn), by Others, 2020-2034
    • Figure 110. Latin America Drug Screening Market Analysis, By End-user, 2020, 2024 and 2034
    • Figure 111. Latin America Drug Screening Market Attractiveness Analysis, By End-user
    • Figure 112. Latin America Drug Screening Market (US$ Mn), by Drug Testing Laboratories, 2020-2034
    • Figure 113. Latin America Drug Screening Market (US$ Mn), by Criminal Justice & Law Enforcement Agencies, 2020-2034
    • Figure 114. Latin America Drug Screening Market (US$ Mn), by Workplace & Schools, 2020-2034
    • Figure 115. Latin America Drug Screening Market (US$ Mn), by Hospitals, 2020-2034
    • Figure 116. Latin America Drug Screening Market (US$ Mn), by Others, 2020-2034
    • Figure 117. Latin America Drug Screening Market Analysis, By Country, 2020, 2024 and 2034
    • Figure 118. Latin America Drug Screening Market Attractiveness Analysis, By Country
    • Figure 119. Middle East & Africa Drug Screening Market Analysis, By Product Type, 2020, 2024 and 2034
    • Figure 120. Middle East & Africa Drug Screening Market Attractiveness Analysis, By Product Type
    • Figure 121. Middle East & Africa Drug Screening Market (US$ Mn), by Consumables, 2020-2034
    • Figure 122. Middle East & Africa Drug Screening Market (US$ Mn), by Equipment, 2020-2034
    • Figure 123. Middle East & Africa Drug Screening Market (US$ Mn), by Laboratory Services, 2020-2034
    • Figure 124. Middle East & Africa Drug Screening Market Analysis, By Sample Type, 2020, 2024 and 2034
    • Figure 125. Middle East & Africa Drug Screening Market Attractiveness Analysis, By Sample Type
    • Figure 126. Middle East & Africa Drug Screening Market (US$ Mn), by Fluid/Saliva, 2020-2034
    • Figure 127. Middle East & Africa Drug Screening Market (US$ Mn), by Breath, 2020-2034
    • Figure 128. Middle East & Africa Drug Screening Market (US$ Mn), by Hair, 2020-2034
    • Figure 129. Middle East & Africa Drug Screening Market (US$ Mn), by Others, 2020-2034
    • Figure 130. Middle East & Africa Drug Screening Market Analysis, By Drug, 2020, 2024 and 2034
    • Figure 131. Middle East & Africa Drug Screening Market Attractiveness Analysis, By Drug
    • Figure 132. Middle East & Africa Drug Screening Market (US$ Mn), by Cannabis/Marijuana, 2020-2034
    • Figure 133. Middle East & Africa Drug Screening Market (US$ Mn), by Alcohol, 2020-2034
    • Figure 134. Middle East & Africa Drug Screening Market (US$ Mn), by Cocaine, 2020-2034
    • Figure 135. Middle East & Africa Drug Screening Market (US$ Mn), by Others, 2020-2034
    • Figure 136. Middle East & Africa Drug Screening Market Analysis, By End-user, 2020, 2024 and 2034
    • Figure 137. Middle East & Africa Drug Screening Market Attractiveness Analysis, By End-user
    • Figure 138. Middle East & Africa Drug Screening Market (US$ Mn), by Drug Testing Laboratories, 2020-2034
    • Figure 139. Middle East & Africa Drug Screening Market (US$ Mn), by Criminal Justice & Law Enforcement Agencies, 2020-2034
    • Figure 140. Middle East & Africa Drug Screening Market (US$ Mn), by Workplace & Schools, 2020-2034
    • Figure 141. Middle East & Africa Drug Screening Market (US$ Mn), by Hospitals, 2020-2034
    • Figure 142. Middle East & Africa Drug Screening Market (US$ Mn), by Others, 2020-2034
    • Figure 143. Middle East & Africa Drug Screening Market Analysis, By Country, 2020, 2024 and 2034
    • Figure 144. Middle East & Africa Drug Screening Market Attractiveness Analysis, By Country
  • settingsSettings

Related Reports

Our Clients

  • Our Clients
Inquiry Before Buying

Drug Screening Market
  • 141277
  • Feb 2025
    • ★★★★★
      ★★★★★
    • (142)
add_shopping_cart Buy Now
Trusted by more than 17382 organizations globally
  • Client Logo
  • Client Logo
  • Client Logo
✖
Request a Sample Report
We'll get back to you as quickly as possible

Single User
$6,000
$3,999
USD / per unit
save 24%
Multi User
$8,000
$5,999
USD / per unit
save 28%
Corporate User
$10,000
$6,999
USD / per unit
save 32%
e-Access
Report Library Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization No up to 10 hrs work up to 30 hrs work
Accessibility 1 User 2-5 User Unlimited
Analyst Support up to 20 hrs up to 40 hrs up to 50 hrs
Benefit Up to 20% off on next purchase Up to 25% off on next purchase Up to 30% off on next purchase
Buy Now ($ 3,999) Buy Now ($ 5,999) Buy Now ($ 6,999)
Find Help
Legal
Explore
Secured Payment Options
Secured Payment Options